Spiropent tablets 10 mcg for bronchodilation and urinary incontinence
What are Spiropent tablets 10 mcg for bronchodilation or urinary incontinence (clenbuterol)?
Spiropent tablets are pharmaceutical formulations comprising hydrochloride salts of clenbuterol, a compound classified as a sympathomimetic amine. This agent exerts multifaceted effects, primarily functioning as a decongestant and bronchodilator, while also demonstrating antiamine properties. By engaging with specific receptors in the sympathetic nervous system, clenbuterol triggers responses that contribute to its therapeutic actions.
As a bronchodilator, clenbuterol facilitates improved respiration by influencing the airway's smooth muscles. Through its interactions with beta-2 adrenergic receptors, clenbuterol prompts relaxation of these muscles, consequently leading to bronchial dilation. This mechanism widens the air passages, making it easier for individuals with conditions like asthma or chronic obstructive pulmonary disease (COPD) to breathe. Additionally, clenbuterol's properties as a decongestant further aid respiratory function by reducing nasal congestion and facilitating smoother airflow.
Apart from its pulmonary effects, clenbuterol also exhibits anti-allergic effects. By modulating the immune response and inflammation processes, the compound assists in mitigating allergic reactions, potentially alleviating symptoms like sneezing, runny nose, and nasal congestion.
Furthermore, Spiropent tablets extend their therapeutic reach beyond the respiratory system. Clenbuterol's influence extends to bladder function, where it elicits relaxation of smooth muscles within the bladder wall. This results in a reduction of intravesical pressure, the pressure exerted within the bladder. Additionally, clenbuterol's impact on the external urinary sphincter—the muscle responsible for controlling the release of urine—fosters increased contraction. This combined effect contributes to an improvement in urinary leakage issues encountered by individuals grappling with stress-related urinary incontinence.
Empirical investigations have delved into the efficacy of clenbuterol, particularly in addressing stress-related urinary incontinence. Results from these studies have revealed that approximately 71.4% of patients afflicted by stress-related urinary incontinence experience a discernible enhancement in their condition subsequent to clenbuterol treatment. This improvement can be attributed to the compound's ability to regulate bladder smooth muscle activity, bolstering both the closure of the external urinary sphincter and the reduction of intravesical pressure.
Active principles: clenbuterol hydrochloride
Amount: 100 tablets
Maker: Teijin Pharma Limited, Tokyo, Japan
1. improving respiratory distress caused by airway obstruction in such diseases as:
- bronchial asthma,
- chronic bronchitis,
- acute bronchitis;
2. treating stress urinary incontinence.
How to take
For bronchial asthma, chronic bronchitis, emphysema or acute bronchitis: adults should take 2 tablets (20 mcg of the active principle) at a time, 2 times a day, in the morning and before bedtime. Children aged 5 years old or over should take 0.3 mcg/kg of body weight) at a time, respectively, 2 times a day, in the morning and before bedtime. If the medicine is taken as needed, in general, for adults, take 2 tablets (20 mcg of the active ingredient) at a time and for children aged 5 years old or over, take 0.3 mcg/kg at a time. Your doctor may adjust the dosage according to your disease, age and symptoms. If the medicine is taken as needed repeatedly, consult with your doctor immediately.
For stress urinary incontinence: adults should take 2 tablets (20 mcg of the active principle) at a time, 2 times a day, in the morning and evening. Your doctor may adjust the dosage according to your age and symptoms. However, the maximum daily dose of 6 tablets (60 mcg) should not be exceeded.
Contraindications: do not use for pregnant or breastfeeding women. Do not use for patients with lower urinary tract obstruction.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.